TY - JOUR
T1 - Crotalus morulus (Viperidae: Crotalinae) envenoming and treatment with F(ab’)2 antivenom
AU - Grossart, Ea
AU - Walter, Fg
AU - Ashley, B.
AU - Keyler, D. E.
N1 - Publisher Copyright:
© 2022
PY - 2022/9
Y1 - 2022/9
N2 - We present the first published case of Tamaulipan Rock Rattlesnake (Crotalus morulus) envenoming. A 54-year-old male professional herpetologist was bitten on the left thumb by a captive C. morulus. Pain, swelling, bruising, and pressure in the thumb were experienced within minutes. On presentation, he reported 7/10 pain and had firm edema in his thumb and thenar eminence. Initial laboratory studies showed normal platelet count, PT, PTT, and creatine kinase. He was treated with pain medication and 10 vials of crotalidae immune F(ab')2 (equine) antivenom approximately 3 h post envenoming. Lymphangitic streaking and axillary lymphadenopathy developed, followed by progression of edema, emergence of a hemorrhagic bulla, and declining platelets, prompting treatment with two additional 10-vial antivenom doses. His platelet count declined to 125 × 103/μL 24 hours post envenoming and he developed numbness in his thumb. Following antivenom therapy completion no further decline in platelets occurred and thrombocytopenia improved to 131 × 103/μL prior to discharge 46 hours post envenoming; fibrinogen, PT, PTT, and CK remained normal. He had no residual signs or symptoms 5 months later. C. morulus venom includes proteolytic venom enzymes that induce local soft tissue destruction, pain, and edema with ecchymosis and blister formation. Although C. morulus venom contains a unique disintegrin, morulustatin, no fibrinogenolytic activity was observed.
AB - We present the first published case of Tamaulipan Rock Rattlesnake (Crotalus morulus) envenoming. A 54-year-old male professional herpetologist was bitten on the left thumb by a captive C. morulus. Pain, swelling, bruising, and pressure in the thumb were experienced within minutes. On presentation, he reported 7/10 pain and had firm edema in his thumb and thenar eminence. Initial laboratory studies showed normal platelet count, PT, PTT, and creatine kinase. He was treated with pain medication and 10 vials of crotalidae immune F(ab')2 (equine) antivenom approximately 3 h post envenoming. Lymphangitic streaking and axillary lymphadenopathy developed, followed by progression of edema, emergence of a hemorrhagic bulla, and declining platelets, prompting treatment with two additional 10-vial antivenom doses. His platelet count declined to 125 × 103/μL 24 hours post envenoming and he developed numbness in his thumb. Following antivenom therapy completion no further decline in platelets occurred and thrombocytopenia improved to 131 × 103/μL prior to discharge 46 hours post envenoming; fibrinogen, PT, PTT, and CK remained normal. He had no residual signs or symptoms 5 months later. C. morulus venom includes proteolytic venom enzymes that induce local soft tissue destruction, pain, and edema with ecchymosis and blister formation. Although C. morulus venom contains a unique disintegrin, morulustatin, no fibrinogenolytic activity was observed.
KW - Antivenom
KW - Crotalus morulus
KW - Envenoming
KW - Morulustatin
KW - Thrombocytopenia
UR - http://www.scopus.com/inward/record.url?scp=85133423834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133423834&partnerID=8YFLogxK
U2 - 10.1016/j.toxicon.2022.06.013
DO - 10.1016/j.toxicon.2022.06.013
M3 - Article
C2 - 35792189
AN - SCOPUS:85133423834
SN - 0041-0101
VL - 216
SP - 45
EP - 49
JO - Toxicon
JF - Toxicon
ER -